Joerg Hager

Title: Joerg Hager: Innovator in Parenteral Solutions

Introduction

Joerg Hager is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of parenteral solutions. His work focuses on enhancing the stability and efficacy of drug preparations.

Latest Patents

Hager holds a patent for a "Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one." This invention relates to new parenteral preparations of 2-phenyl-1.2-benzisoselenazol-3(2H)-one (Ebselen), which includes one or several phospholipids and possibly additional auxiliary agents. The patent also outlines a process for producing such solutions and their application in drug preparations of Ebselen.

Career Highlights

Joerg Hager is associated with A. Nattermann & Cie GmbH, where he has been instrumental in advancing pharmaceutical innovations. His expertise in the field has led to the development of effective drug formulations that benefit patients.

Collaborations

Hager has collaborated with notable colleagues, including Andrea M. Huether and Joachim Roeding. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Joerg Hager's contributions to the pharmaceutical industry, particularly through his patent on stable parenteral solutions, highlight his role as an innovator. His work continues to impact the field positively, paving the way for advancements in drug preparation and delivery.